Company Profile
Shenzhen Yuanyang Chemical Technologe Co.,Ltd is involved in design, research, development and production of fine chemicals, API related compounds, impurities, intermediates, metabolites, internal standards etc. using chemical synthesis and bio-fermentation processes.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Acotiamide Impurity 1 |
185103-81-5 | Inquiry | ||
Acotiamide Impurity 1 |
185103-81-5 | Inquiry | ||
Acotiamide Impurity 10 |
2-amino-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole;2-amino-N-[2-[di(propan-2-yl)amino]ethyl]-1,3-thiazole-4-carboxamide;206882-15-7;SCHEMBL6981525;AKOS012087949 |
206882-15-7 | Inquiry | |
Acotiamide Impurity 10 |
2-amino-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole;2-amino-N-[2-[di(propan-2-yl)amino]ethyl]-1,3-thiazole-4-carboxamide;206882-15-7;SCHEMBL6981525;AKOS012087949 |
206882-15-7 | Inquiry | |
Acotiamide Impurity 11 |
2-aminothiazole-4-carboxamide;4-Thiazolecarboxamide,2-amino-(9CI);2-AMINOTHIAZOLE-4-CARBOXAMIDE,PURITY:97% MIN(HPLC);2-amino-1,3-thiazole-4-carboxamide;2-Amino-1,3-thiazole-4-carboamide |
118452-02-1 | Inquiry | |
Acotiamide Impurity 11 |
2-aminothiazole-4-carboxamide;4-Thiazolecarboxamide,2-amino-(9CI);2-AMINOTHIAZOLE-4-CARBOXAMIDE,PURITY:97% MIN(HPLC);2-amino-1,3-thiazole-4-carboxamide;2-Amino-1,3-thiazole-4-carboamide |
118452-02-1 | Inquiry | |
Acotiamide Impurity 5 |
185106-01-8 | Inquiry | ||
Acotiamide Impurity 5 |
185106-01-8 | Inquiry | ||
Acotiamide Impurity 7 |
Methyl 2-(2-hydroxy-4,5-diMethoxybenzaMido)thiazole-4-carboxylate;2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylic acid methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester(for Acotiamide);Acotiamide-020;4-Thiazolecarboxylic acid, 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester;4-Thiazolecarboxylic acid, 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-car... |
877997-99-4 | Inquiry | |
Acotiamide Impurity 7 |
Methyl 2-(2-hydroxy-4,5-diMethoxybenzaMido)thiazole-4-carboxylate;2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylic acid methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester(for Acotiamide);Acotiamide-020;4-Thiazolecarboxylic acid, 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester;4-Thiazolecarboxylic acid, 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-, methyl ester;2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-car... |
877997-99-4 | Inquiry | |
Acotiamide Impurity 8 |
5722-93-0 | Inquiry | ||
Acotiamide Impurity 8 |
5722-93-0 | Inquiry | ||
Acotiamide Reference Standards |
4-Thiazolecarboxamide,N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-;N-[2-[Bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide;Acotiamide |
185106-16-5 | Inquiry | |
Acotiamide Reference Standards |
4-Thiazolecarboxamide,N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-;N-[2-[Bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide;Acotiamide |
185106-16-5 | Inquiry | |
Afatinib Reference Standard |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;Afatinib;BIBW 2992;Tovok;Gilotrif;Giotrif |
850140-72-6 | Inquiry | |
Afatinib Reference Standard |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;Afatinib;BIBW 2992;Tovok;Gilotrif;Giotrif |
850140-72-6 | Inquiry | |
Bortezomib Hydroxy (1R, 2S)-Isomer |
289472-78-2 | Inquiry | ||
Bortezomib Hydroxy (1R, 2S)-Isomer |
289472-78-2 | Inquiry | ||
Bortezomib Hydroxy (1S, 2S)-Isomer |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-;(S)-Hydroxy Des(boric Acid) BortezoMib;Bortezomib Impurity 48;Bortezomib Impurity J;N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide;Bortezomib USP IMP J;(N-[(1S)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide |
289472-81-7 | Inquiry | |
Bortezomib Hydroxy (1S, 2S)-Isomer |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-;(S)-Hydroxy Des(boric Acid) BortezoMib;Bortezomib Impurity 48;Bortezomib Impurity J;N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide;Bortezomib USP IMP J;(N-[(1S)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide |
289472-81-7 | Inquiry |
CONTACT INFORMATION
Sign In for Details